Global Ascariasis Treatment and Management Market is expected to grow at a CAGR of 3.84% during the forecast period. Global Ascariasis Treatment and Management Market is expected to reach US$ 890 Mn. by 2027. The roundworm Ascariasis Lumbricoides, is one of the most prevalent parasites residing in the alimentary canal of human beings. The infections are most common in developing countries with a tropical climate where sanitation and hygiene are poor. The prevalence of this condition is rising in industrialized countries because of immigration and increasing number of refugees.Poor personal hygiene and poor sanitation in under developed countries is the prime factor contributing towards the increasing cases. Adults are known to harbor the helminthes at a low intensity whereas the disease is highly prevalent in children’s. WHO advices a target treatment two to three times a year. Several initiatives regarding health education are conducted by CDC and WHO to reduce the mortality rate and eradicate helminthes. The initiatives taken and rising prevalence of the disease are contributing to the market growth. Anthelminthic medications such as albendazole and mebendazole are recommended for treating the Ascariasis infection. The treatment and management market for this infection is expected to grow, reason being the usage of medications at high rate. If the condition is serious, the option for surgery is recommended. The report covers the detailed analysis of global market for Ascariasis Treatment and Managementwith the classifications of the market based on product type, distribution channels and region. Analysis of past market dynamics from 2016 to 2019 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it. The report has profiled eleven key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques. Report has come up with recommendations for future hot spot in APAC region. New research findings, funding policies for projects and its impact on Ascariasis Treatment and Management market are covered in the report.Global Ascariasis Treatment and Management Market Segment Analysis
The product type segment for Ascariasis treatment and management market is expected to witness a growth of $xx Mn in the forecast period. Anti-parasite medications are preferred by patients for the treatment of this disease. Anti-parasite medications such as Albendazole, Mebendazole, Levamisole, piperazine, Tiabendazole are prescribed more often. The length of treatment is quite short depending on the worm infection. If the infection is more serious a surgery is recommended.To know about the Research Methodology :- Request Free Sample Report
Global Ascariasis Treatment and Management Market Segmentation
The market for Ascariasis Treatment and management is segmented based on-Product Type
• Anti-parasite medications • SurgeryDistribution Channel
• Hospital Pharmacies • Retail Pharmacies • E-commerceScope of Global Ascariasis Treatment and Management Market :Inquire before buying
Global Ascariasis Treatment and Management Market Regional insights
The Ascariasis treatment and management market is expected to remain dominant in the tropical and sub-tropical regions of the world. Latin America is expected to be the second most prevalent region. In the MEA region, the disease is more prevalent due to low economic status and poor personal hygiene. The south Asian countries- Indonesia, Malaysia, Thailand and Vietnam are also highly affected with the disease. North America is having less prevalence of the disease due to increasing awareness and maintenance of personal hygiene. Highly developed infrastructure in the region and hygiene measures followed are helping prevent the disease spread.
Key Players operating the Global Ascariasis Treatment and Management Market
• Johnson & Johnson • Amedra Pharmaceuticals LLC • CiplaInc • Cadila Pharmaceuticals Ltd • Quartz Pharmaceuticals LLC • Merck & Co, Inc • Romark Laboratories The objective of the report is to present a comprehensive analysis of the Global Ascariasis Treatment and Management Market of all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Ascariasis Treatment and Management Market dynamics, structure by analysing the market segments and project the Global Ascariasis Treatment and Management Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Ascariasis Treatment and Management Market make the report investor’s guide.
Global Ascariasis Treatment and Management Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: ASCARIASIS TREATMENT AND MANAGEMENT Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis and Forecast 6.1. ASCARIASIS TREATMENT AND MANAGEMENT Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis and Forecast, By Product Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Product Type 7.4. ASCARIASIS TREATMENT AND MANAGEMENT Market Size (US$ Mn) Forecast, By Product Type 7.5. ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis, By Product Type 7.6. ASCARIASIS TREATMENT AND MANAGEMENT Market Attractiveness Analysis, By Product Type 8. Global ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis and Forecast, By Distribution Channel 8.1. Introduction and Definition 8.2. Key Findings 8.3. ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Distribution Channel 8.4. ASCARIASIS TREATMENT AND MANAGEMENT Market Size (US$ Mn) Forecast, By Distribution Channel 8.5. ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis, By Distribution Channel 8.6. ASCARIASIS TREATMENT AND MANAGEMENT Market Attractiveness Analysis, By Distribution Channel 9. Global ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis, By Region 9.1. ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Region 9.2. ASCARIASIS TREATMENT AND MANAGEMENT Market Size (US$ Mn) Forecast, By Region 9.3. ASCARIASIS TREATMENT AND MANAGEMENT Market Attractiveness Analysis, By Region 10. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis 10.1. Key Findings 10.2. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Overview 10.3. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Product Type 10.4. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 10.4.1. Anti-parasite medications 10.4.2. Surgery 10.5. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Distribution Channel 10.6. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 10.6.1. Hospital Pharmacies 10.6.2. Retail Pharmacies 10.6.3. E-commerce 10.7. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Country 10.8. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis, By Country 10.10. U.S. ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 10.10.1. Anti-parasite medications 10.10.2. Surgery 10.11. U.S. ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 10.11.1. Hospital Pharmacies 10.11.2. Retail Pharmacies 10.11.3. E-commerce 10.12. Canada ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 10.12.1. Anti-parasite medications 10.12.2. Surgery 10.13. Canada ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 10.13.1. Hospital Pharmacies 10.13.2. Retail Pharmacies 10.13.3. E-commerce 10.14. Mexico ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 10.14.1. Anti-parasite medications 10.14.2. Surgery 10.15. Mexico ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 10.15.1. Hospital Pharmacies 10.15.2. Retail Pharmacies 10.15.3. E-commerce 10.16. North America ASCARIASIS TREATMENT AND MANAGEMENT Market Attractiveness Analysis 10.16.1. By Product Type 10.16.2. By Distribution Channel 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis 11.1. Key Findings 11.2. Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Overview 11.3. Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Product Type 11.4. Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 11.4.1. Anti-parasite medications 11.4.2. Surgery 11.5. Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Distribution Channel 11.6. Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 11.6.1. Hospital Pharmacies 11.6.2. Retail Pharmacies 11.6.3. E-commerce 11.7. Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Country 11.8. Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 11.9.1. Anti-parasite medications 11.9.2. Surgery 11.10. Germany ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 11.10.1. Hospital Pharmacies 11.10.2. Retail Pharmacies 11.10.3. E-commerce 11.11. U.K. ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 11.11.1. Anti-parasite medications 11.11.2. Surgery 11.12. U.K. ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 11.12.1. Hospital Pharmacies 11.12.2. Retail Pharmacies 11.12.3. E-commerce 11.13. France ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 11.13.1. Anti-parasite medications 11.13.2. Surgery 11.14. France ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 11.14.1. Hospital Pharmacies 11.14.2. Retail Pharmacies 11.14.3. E-commerce 11.15. Italy ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 11.15.1. Anti-parasite medications 11.15.2. Surgery 11.16. Italy ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 11.16.1. Hospital Pharmacies 11.16.2. Retail Pharmacies 11.16.3. E-commerce 11.17. Spain ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 11.17.1. Anti-parasite medications 11.17.2. Surgery 11.18. Spain ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 11.18.1. Hospital Pharmacies 11.18.2. Retail Pharmacies 11.18.3. E-commerce 11.19. Sweden ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 11.19.1. Anti-parasite medications 11.19.2. Surgery 11.20. Sweden ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 11.20.1. Hospital Pharmacies 11.20.2. Retail Pharmacies 11.20.3. E-commerce 11.21. CIS countries ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 11.21.1. Anti-parasite medications 11.21.2. Surgery 11.22. CIS countries ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 11.22.1. Hospital Pharmacies 11.22.2. Retail Pharmacies 11.22.3. E-commerce 11.23. Rest of Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 11.23.1. Anti-parasite medications 11.23.2. Surgery 11.24. Rest of Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 11.24.1. Hospital Pharmacies 11.24.2. Retail Pharmacies 11.24.3. E-commerce 11.25. Europe ASCARIASIS TREATMENT AND MANAGEMENT Market Attractiveness Analysis 11.25.1. By Distribution Channel 11.25.2. By Product Type 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis 12.1. Key Findings 12.2. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Overview 12.3. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Product Type 12.4. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 12.4.1. Anti-parasite medications 12.4.2. Surgery 12.5. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Distribution Channel 12.6. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 12.6.1. Hospital Pharmacies 12.6.2. Retail Pharmacies 12.6.3. E-commerce 12.7. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Country 12.8. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis, By Country 12.10. China ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 12.10.1. Anti-parasite medications 12.10.2. Surgery 12.11. China ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 12.11.1. Hospital Pharmacies 12.11.2. Retail Pharmacies 12.11.3. E-commerce 12.12. India ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 12.12.1. Anti-parasite medications 12.12.2. Surgery 12.13. India ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 12.13.1. Hospital Pharmacies 12.13.2. Retail Pharmacies 12.13.3. E-commerce 12.14. Japan ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 12.14.1. Anti-parasite medications 12.14.2. Surgery 12.15. Japan ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 12.15.1. Hospital Pharmacies 12.15.2. Retail Pharmacies 12.15.3. E-commerce 12.16. South Korea ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 12.16.1. Anti-parasite medications 12.16.2. Surgery 12.17. South Korea ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 12.17.1. Hospital Pharmacies 12.17.2. Retail Pharmacies 12.17.3. E-commerce 12.18. Australia ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 12.18.1. Anti-parasite medications 12.18.2. Surgery 12.19. Australia ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 12.19.1. Hospital Pharmacies 12.19.2. Retail Pharmacies 12.19.3. E-commerce 12.20. ASEAN ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 12.20.1. Anti-parasite medications 12.20.2. Surgery 12.21. ASEAN ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 12.21.1. Hospital Pharmacies 12.21.2. Retail Pharmacies 12.21.3. E-commerce 12.22. Rest of Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 12.22.1. Anti-parasite medications 12.22.2. Surgery 12.23. Rest of Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 12.23.1. Hospital Pharmacies 12.23.2. Retail Pharmacies 12.23.3. E-commerce 12.24. Asia Pacific ASCARIASIS TREATMENT AND MANAGEMENT Market Attractiveness Analysis 12.24.1. By Product Type 12.24.2. By Distribution Channel 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis 13.1. Key Findings 13.2. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Overview 13.3. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Product Type 13.4. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 13.4.1. Anti-parasite medications 13.4.2. Surgery 13.5. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Distribution Channel 13.6. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 13.6.1. Hospital Pharmacies 13.6.2. Retail Pharmacies 13.6.3. E-commerce 13.7. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Country 13.8. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis, By Country 13.10. GCC Countries ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 13.10.1. Anti-parasite medications 13.10.2. Surgery 13.11. GCC Countries ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 13.11.1. Hospital Pharmacies 13.11.2. Retail Pharmacies 13.11.3. E-commerce 13.12. South Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 13.12.1. Anti-parasite medications 13.12.2. Surgery 13.13. South Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 13.13.1. Hospital Pharmacies 13.13.2. Retail Pharmacies 13.13.3. E-commerce 13.14. Nigeria ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 13.14.1. Anti-parasite medications 13.14.2. Surgery 13.15. Nigeria ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 13.15.1. Hospital Pharmacies 13.15.2. Retail Pharmacies 13.15.3. E-commerce 13.16. Egypt ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 13.16.1. Anti-parasite medications 13.16.2. Surgery 13.17. Egypt ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 13.17.1. Hospital Pharmacies 13.17.2. Retail Pharmacies 13.17.3. E-commerce 13.18. Rest of Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 13.18.1. Anti-parasite medications 13.18.2. Surgery 13.19. Rest of Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 13.19.1. Hospital Pharmacies 13.19.2. Retail Pharmacies 13.19.3. E-commerce 13.20. Middle East & Africa ASCARIASIS TREATMENT AND MANAGEMENT Market Attractiveness Analysis 13.20.1. By Product Type 13.20.2. By Distribution Channel 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis 14.1. Key Findings 14.2. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Overview 14.3. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Product Type 14.4. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 14.4.1. Anti-parasite medications 14.4.2. Surgery 14.5. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Distribution Channel 14.6. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 14.6.1. Hospital Pharmacies 14.6.2. Retail Pharmacies 14.6.3. E-commerce 14.7. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Value Share Analysis, By Country 14.8. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Analysis, By Country 14.10. Brazil ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 14.10.1. Anti-parasite medications 14.10.2. Surgery 14.11. Brazil ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 14.11.1. Hospital Pharmacies 14.11.2. Retail Pharmacies 14.11.3. E-commerce 14.12. Colombia ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 14.12.1. Anti-parasite medications 14.12.2. Surgery 14.13. Colombia ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 14.13.1. Hospital Pharmacies 14.13.2. Retail Pharmacies 14.13.3. E-commerce 14.14. Argentina ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 14.14.1. Anti-parasite medications 14.14.2. Surgery 14.15. Argentina ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 14.15.1. Hospital Pharmacies 14.15.2. Retail Pharmacies 14.15.3. E-commerce 14.16. Rest of South America ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Product Type 14.16.1. Anti-parasite medications 14.16.2. Surgery 14.17. Rest of South America ASCARIASIS TREATMENT AND MANAGEMENT Market Forecast, By Distribution Channel 14.17.1. Hospital Pharmacies 14.17.2. Retail Pharmacies 14.17.3. E-commerce 14.18. South America ASCARIASIS TREATMENT AND MANAGEMENT Market Attractiveness Analysis 14.18.1. By Product Type 14.18.2. By Distribution Channel 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, Distribution Channel, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and Distribution Channel 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Johnson & Johnson 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Amedra Pharmaceuticals LLC 15.3.3. CiplaInc 15.3.4. Cadila Pharmaceuticals Ltd 15.3.5. Quartz Pharmaceuticals LLC 15.3.6. Merck & Co, Inc 15.3.7. Romark Laboratories